These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The usefulness of 4-amino-3-hydroxyphenylalanine as a specific marker of pheomelanin. Wakamatsu K, Ito S, Rees JL. Pigment Cell Res; 2002 Jun; 15(3):225-32. PubMed ID: 12028587 [Abstract] [Full Text] [Related]
4. Comparison of phaeomelanin and its precursor 5-S-cysteinyldopa in the serum of melanoma patients. Wakamatsu K, Yokochi M, Naito A, Kageshita T, Ito S. Melanoma Res; 2003 Aug; 13(4):357-63. PubMed ID: 12883361 [Abstract] [Full Text] [Related]
7. Determination of eumelanin in human urine. Wakamatsu K, Takasaki A, Kågedal B, Kageshita T, Ito S. Pigment Cell Res; 2006 Apr; 19(2):163-9. PubMed ID: 16524432 [Abstract] [Full Text] [Related]
17. Cysteinyldopa isomers and dopa in lesions and urine of Japanese patients with malignant melanoma. Morishima T, Tatsumi F, Fukada E, Saito M, Fujita M, Nagashima N, Hanawa S. Arch Dermatol Res; 1983 Jul 24; 275(2):76-9. PubMed ID: 6409012 [Abstract] [Full Text] [Related]
18. Measurement of eumelanin precursor metabolites in the urine as a new marker for melanoma metastases. Yamada K, Walsh N, Hara H, Jimbow K, Chen H, Ito S. Arch Dermatol; 1992 Apr 24; 128(4):491-4. PubMed ID: 1580656 [Abstract] [Full Text] [Related]